VIDEO: Acid Assets! How Psychedelics Are Becoming Pharma's Hottest Commodity
By John Persinos
Welcome to my latest video presentation, for Thursday, May 30. Below is a condensed transcript; the video contains several charts and further details.
In the U.S. alone, about 8.9 million adults take antidepressants to treat depressive disorders. However, for about 30% of these suffering souls, the medications don't work. Hence the enormous opportunity for psychedelics, as a treatment and a business.
To date, more than 50 publicly traded companies have emerged to tap into the psychedelics mega-trend. Many of these companies also are researching the medicinal benefits of marijuana.
"Big Pharma" is plowing considerable resources into researching psychedelics, helping pull these drugs into the pharmaceutical mainstream.
LSD and magic mushrooms have gone from a hippie movement to an extremely lucrative market. When the U.S. Food and Drug Administration (FDA) and other federal authorities remove legal impediments (and one day they will), the market will mushroom…pun intended.
Psilocybin (the active ingredient in magic mushrooms), lysergic acid diethylamide (LSD), and similar mind-bending psychotropic substances remain illegal at the federal level in the United States. These drugs have been flash points in the American culture wars for decades.
Psychedelics is on the cusp of becoming a multi-billion-dollar juggernaut. It's only a matter of when, not if, that psychedelics and marijuana become legal on the federal level, and then the investment floodgates will swing wide open.
Read More...
댓글 없음:
댓글 쓰기